Two opposite effects of Δ9-tetrahydrocannabinol on subthalamic nucleus neuron activity: Involvement of GABAergic and glutamatergic neurotransmission

Synapse

Volumn 64, Issue 1, 2010, Pages 20-29

  Morera Herreras, Teresa ^a   Ruiz Ortega, Jose Angel ^a   Ugedo, Luisa ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Basal ganglia; Cannabinoid; Electrophysiology

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; BICUCULLINE; CANNABINOID RECEPTOR; DRONABINOL; EXCITATORY AMINO ACID RECEPTOR; GLUTAMIC ACID; IBOTENIC ACID; KYNURENIC ACID; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCITATION; GLOBUS PALLIDUS; INHIBITION KINETICS; MALE; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBTHALAMIC NUCLEUS;

ANIMALS; GAMMA-AMINOBUTYRIC ACID; GLUTAMINE; HALLUCINOGENS; MALE; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, GABA-A; SUBTHALAMIC NUCLEUS; SYNAPTIC TRANSMISSION; TETRAHYDROCANNABINOL;

EID: 72449198035     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20701     Document Type: Article

References (51)

1. A IPSPs. J Neurophysiol 87:1348-1362.
2. Breit S, Bouali-Benazzouz R, Popa RC, Gasser T, Benabid AL, Benazzouz A. 2007. Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat. Exp Neurol 205:36-47. (Pubitemid 46617488)
3. Carpenter MB, Carleton SC, Keller JT, Conte P. 1981. Connections of the subthalamic nucleus in the monkey. Brain Res 224:1-29.
4. Crossman AR. 2000. Functional anatomy of movement disorders. J Anat 196:519-525.
5. Feger J, Bevan M, Crossman AR. 1994. The projections from the parafascicular thalamic nucleus to the subthalamic nucleus and the striatum arise from separate neuronal populations: A comparison with the corticostriatal and corticosubthalamic efferents in a retrograde fluorescent double-labelling study. Neuroscience 60:125-132. (Pubitemid 24147612)
6. Freiman I, Szabo B. 2005. Cannabinoids depress excitatory neurotransmission between the subthalamic nucleus and the globus pallidus. Neuroscience 133:305-313. (Pubitemid 40694179)
7. Groenewegen HJ, Berendse HW. 1990. Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat. J Comp Neurol 294:607-622.
8. B receptors. J Neurosci 25:6304-6315.
9. Hamani C, Saint-Cyr JA, Fraser J, Kaplitt M, Lozano AM. 2004. The subthalamic nucleus in the context of movement disorders. Brain 127(Pt 1):4-20. (Pubitemid 38055342)
10. Hassani OK, Mouroux M, Feger J. 1996. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience 72:105-115. (Pubitemid 26092990)
11. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. 1991. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci 11:563-583.
12. Hollerman JR, Grace AA. 1992. Subthalamic nucleus cell firing in the 6-OHDA-treated rat: Basal activity and response to haloperidol. Brain Res 590:291-299.
13. Julian MD, Martin AB, Cuellar B, Rodriguez De Fonseca F, Navarro M, Moratalla R, Garcia-Segura LM. 2003. Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia. Neuroscience 119:309-318. (Pubitemid 36577432)
14. Kaneoke Y, Vitek JL. 1996. Burst and oscillation as disparate neuronal properties. J Neurosci Methods 68:211-223. (Pubitemid 26345963)
15. Kitai ST, Kita H. 1987.Anatomy and physiology of the subthalamic nucleus: A driving force of the basal ganglia. In:Jayaraman A, Carpenter MB, editors. The Basal Ganglia. New York: Plenum Press. p 357-373.
16. Konitsiotis S, Kafetzopoulos E, Anastasopoulos D, Blanchet PJ. 1998. Opposite rotation induced by dopamine agonists in rats with unilateral lesions of the globus pallidus or substantia nigra. Behav Brain Res 92:77-83. (Pubitemid 28179609)
17. Mailleux P, Vanderhaeghen JJ. 1992. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48:655-668.
18. 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus. Eur J Pharmacol 308:161-164.
19. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564. (Pubitemid 20238806)
20. Matsuda LA, Bonner TI, Lolait SJ. 1993. Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327:535-550. (Pubitemid 23033649)
21. Maurice N, Deniau JM, Glowinski J, Thierry AM. 1998. Relationships between the prefrontal cortex and the basal ganglia in the rat: Physiology of the corticosubthalamic circuits. J Neurosci 18:9539-9546. (Pubitemid 28512482)
22. Mechoulam R, Shani A, Edery H, Grunfeld Y. 1970. Chemical basis of hashish activity. Science 169:611-612.
23. Miller AS, Walker JM. 1996. Electrophysiological effects of a cannabinoid on neural activity in the globus pallidus. Eur J Pharmacol 304:29-35.
24. Miller AS, Sanudo-Pena MC, Walker JM. 1998. Ipsilateral turning behavior induced by unilateral microinjections of a cannabinoid into the rat subthalamic nucleus. Brain Res 793:7-11.
25. Miwa H, Nishi K, Fuwa T, Mizuno Y. 1998. Globus pallidus lesions inhibit the induction of c-Fos by haloperidol in the basal ganglia output nuclei in rats. Neurosci Lett 250:29-32. (Pubitemid 28341769)
26. Munro S, Thomas KL, Abu-Shaar M. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65. (Pubitemid 23305569)
27. Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Lanciego JL, Artieda J, Gonzalo N, Olanow CW. 2000. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci 23(10 Suppl):S8-S19. (Pubitemid 30949971)
28. Parent A, Hazrati LN. 1995. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 20:128-154.
29. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinated, 2nd ed. Orlando: Academic Press.
30. Perier C, Tremblay L, Feger J, Hirsch EC. 2002. Behavioral consequences of bicuculline injection in the subthalamic nucleus and the zona incerta in rat. J Neurosci 22:8711-8719. (Pubitemid 35387612)
31. Pertwee RG. 2006. Cannabinoid pharmacology: The first 66 years. Br J Pharmacol 147(Suppl 1):S163-S171.
32. Pistis M, Ferraro L, Pira L, Flore G, Tanganelli S, Gessa GL, Devoto P. 2002. δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: An in vivo microdialysis study. Brain Res 948:155-158. (Pubitemid 35283774)
33. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrié P, Brelière JC, LeFur G. 1994. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244. (Pubitemid 24268029)
34. Robledo P, Feger J. 1990. Excitatory in.uence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: Electrophysiological data. Brain Res 518:47-54. (Pubitemid 20197029)
35. Romero J, de Miguel R, Ramos JA, Fernandez-Ruiz JJ. 1998. The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake. Life Sci 62:351-363. (Pubitemid 28018188)
36. 9-Tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons. Neuroscience 151:320-328.
37. Sanudo-Pena MC, Romero J, Seale GE, Fernandez-Ruiz JJ, Walker JM. 2000. Activational role of cannabinoids on movement. Eur Pharmacol 391:269-274.
38. Schlicker E, Kathmann M. 2001. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 22:565-572. (Pubitemid 33042646)
39. Shi LH, Luo F, Woodward DJ, Chang JY. 2005. Dose and behavioral context dependent inhibition of movement and basal ganglia neural activity by δ-9-tetrahydrocannabinol during spontaneous and treadmill locomotion tasks in rats. Synapse 55:1-16. (Pubitemid 39565223)
40. Shink E, Bevan MD, Bolam JP, Smith Y. 1996. The subthalamic nucleus and the external pallidum: Two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neuroscience 73:335-357. (Pubitemid 26168797)
41. Smith Y, Parent A. 1988. Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity. Brain Res 453:353-356. (Pubitemid 18154783)
42. Smith Y, Bolam JP, Von Krosigk M. 1990. Topographical and synaptic organization of the GABA-containing pallidosubthalamic projection in the rat. Eur J Neurosci 2:500-511. (Pubitemid 20177231)
43. Szabo B, Wallmichrath I, Mathonia P, Pfreundtner C. 2000. Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata. Neuroscience 97:89-97. (Pubitemid 30195879)
44. Tseng AH, Craft RM. 2004. CB1 receptor mediation of cannabinoid behavioral effects in male and female rats. Psychopharmacology (Berl) 172:25-30. (Pubitemid 38299747)
45. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. 1998. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393-411. (Pubitemid 28062631)
46. Urbain N, Rentero N, Gervasoni D, Renaud B, Chouvet G. 2002. The switch of subthalamic neurons from an irregular to a bursting pattern does not solely depend on their GABAergic inputs in the anesthetic-free rat. J Neurosci 22:8665-8675. (Pubitemid 35387607)
47. Urbain N, Vautrelle N, Dahan L, Savasta M, Chouvet G. 2004. Glutamatergic-receptors blockade does not regularize the slow wave sleep bursty pattern of subthalamic neurons. Eur J Neurosci 20:392-402. (Pubitemid 38969625)
48. Varvel SA, Bridgen DT, Tao Q, Thomas BF, Martin BR, Lichtman AH. 2005. δ9-Tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. J Pharmacol Exp Ther 314:329-337. (Pubitemid 41058270)
49. Vincent SR, Kimura H, McGeer EG. 1982. A histochemical study of GABA-transaminase in the efferents of the pallidum. Brain Res 241:162-165.
50. Weinstein A, Brickner O, Lerman H, Greemland M, Bloch M, Lester H, Chisin R, Mechoulam R, Bar-Hamburger R, Freedman N, Even-Sapir E. 2008. Brain imaging study of the acute effects of δ9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana. Psychopharmacology (Berl) 196:119-131.
51. Windels F, Carcenac C, Poupard A, Savasta M. 2005. Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus. J Neurosci 25:5079-5086. (Pubitemid 40712852)